UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

JAK2V617F allele burden in polycythemia vera: burden of proof

Blood, 2023-04, Vol.141 (16), p.1934-1942

2023

Volltextzugriff (PDF)

Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms

Blood, 2017-12, Vol.130 (26), p.2848-2859

2017

Volltextzugriff (PDF)

Modified Ham test for atypical hemolytic uremic syndrome

Blood, 2015-06, Vol.125 (23), p.3637-3646

2015

Volltextzugriff (PDF)

HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression

Blood, 2022-05, Vol.139 (18), p.2797-2815

2022

Volltextzugriff (PDF)

Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies

Leukemia, 2013-06, Vol.27 (6), p.1301-1309

2013

Volltextzugriff (PDF)

The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN

Frontiers in oncology, 2021-03, Vol.11, p.641613-641613

2021

Volltextzugriff (PDF)

The Gamma Gap and All-Cause Mortality

PloS one, 2015-12, Vol.10 (12), p.e0143494-e0143494

2015

Volltextzugriff (PDF)

Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology

International journal of molecular sciences, 2021-03, Vol.22 (5), p.2595

2021

Volltextzugriff (PDF)

Gamma gap thresholds and HIV, hepatitis C, and monoclonal gammopathy

PloS one, 2020-01, Vol.15 (1), p.e0224977-e0224977

2020

Volltextzugriff (PDF)

Clinical insights into the origins of thrombosis in myeloproliferative neoplasms

Blood, 2021-03, Vol.137 (9), p.1145-1153

2021

Volltextzugriff (PDF)

Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies

Leukemia, 2010-10, Vol.24 (10), p.1799-1804

2010

Volltextzugriff (PDF)

Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies

Leukemia, 2013-09, Vol.27 (9), p.1943-1946

2013

Volltextzugriff (PDF)

Thrombopoietin is required for full phenotype expression in a JAK2V617F transgenic mouse model of polycythemia vera

PloS one, 2020-06, Vol.15 (6), p.e0232801-e0232801

2020

Volltextzugriff (PDF)

Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes

Haematologica (Roma), 2011-10, Vol.96 (10), p.1462-1469

2011

Volltextzugriff (PDF)

Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency

International journal of hematology, 2023-03, Vol.117 (3), p.456-462

2023

Volltextzugriff (PDF)

Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis

Blood, 2012-06, Vol.119 (25), p.6109-6117

2012

Volltextzugriff (PDF)

Solvent detergent treated pooled plasma and reduction of allergic transfusion reactions

Transfusion (Philadelphia, Pa.), 2020-01, Vol.60 (1), p.54-61

2020

Volltextzugriff (PDF)

Platelet Counts Differ by Sex, Ethnicity, and Age in the United States

Annals of epidemiology, 2006-02, Vol.16 (2), p.123-130

2006

Volltextzugriff (PDF)

Age-related differences in disease characteristics and clinical outcomes in polycythemia vera

Leukemia & lymphoma, 2013-09, Vol.54 (9), p.1989-1995

2013

Volltextzugriff (PDF)

Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment options

Annals of hematology, 2014-12, Vol.93 (12), p.1965-1976

2014

Volltextzugriff (PDF)

Successful use of emicizumab in a patient with refractory acquired hemophilia A and acute coronary syndrome requiring percutaneous coronary intervention

Research and practice in thrombosis and haemostasis, 2019-07, Vol.3 (3), p.420-423

2019

Volltextzugriff (PDF)

JAK2 V617F allele burden in polycythemia vera: burden of proof

Blood, 2023-04, Vol.141 (16), p.1934-1942

2023

Volltextzugriff (PDF)

Deep learning for diagnosis of acute promyelocytic leukemia via recognition of genomically imprinted morphologic features

NPJ precision oncology, 2021-05, Vol.5 (1), p.38-38, Article 38

2021

Volltextzugriff (PDF)

Primary myelofibrosis and the myeloproliferative neoplasms: the role of individual variation

JAMA : the journal of the American Medical Association, 2010-06, Vol.303 (24), p.2513

2010

Volltextzugriff (PDF)

Applied genomics in MPN presentation

Hematology, 2020-12, Vol.2020 (1), p.434-439

2020

Volltextzugriff (PDF)

1 – 25 von 501

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(423)
Mit Volltextzugriff
(446)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(249)
Life Sciences & Biomedicine
(242)
Humans
(241)
Female
(138)
Male
(130)
Biological And Medical Sciences
(121)
Medical Sciences
(120)
Cardiovascular System & Cardiology
(112)
Middle Aged
(109)
Cardiac & Cardiovascular Systems
(103)
Aged
(93)
Hematology
(63)
Adult
(55)
Cardiology. Vascular System
(55)
Treatment Outcome
(54)
Heart
(44)
Platelet Aggregation Inhibitors - Therapeutic Use
(42)
Coronary Heart Disease
(40)
Risk Factors
(39)
Peripheral Vascular Disease
(38)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

JAK2V617F allele burden in polycythemia vera: burden of proof

Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms

Modified Ham test for atypical hemolytic uremic syndrome

HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression

Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies

The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN

The Gamma Gap and All-Cause Mortality

Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology

Gamma gap thresholds and HIV, hepatitis C, and monoclonal gammopathy

Clinical insights into the origins of thrombosis in myeloproliferative neoplasms

Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies

Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies

Thrombopoietin is required for full phenotype expression in a JAK2V617F transgenic mouse model of polycythemia vera

Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes

Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency

Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis

Solvent detergent treated pooled plasma and reduction of allergic transfusion reactions

Platelet Counts Differ by Sex, Ethnicity, and Age in the United States

Age-related differences in disease characteristics and clinical outcomes in polycythemia vera

Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment options

Successful use of emicizumab in a patient with refractory acquired hemophilia A and acute coronary syndrome requiring percutaneous coronary intervention

JAK2 V617F allele burden in polycythemia vera: burden of proof

Deep learning for diagnosis of acute promyelocytic leukemia via recognition of genomically imprinted morphologic features

Primary myelofibrosis and the myeloproliferative neoplasms: the role of individual variation

Applied genomics in MPN presentation

Suchergebnisse filtern